Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Rev. cuba. estomatol ; 57(2): e1775, abr.-jun. 2020. tab
Artigo em Espanhol | LILACS, CUMED | ID: biblio-1126498

RESUMO

RESUMEN Introducción: La enfermedad por reflujo gastroesofágico es un trastorno funcional, multifactorial, del tracto gastrointestinal superior. Las alteraciones bucales han sido consideradas como parte de sus manifestaciones extraesofágicas. Objetivo: Determinar las alteraciones bucales encontradas en pacientes con enfermedad por reflujo gastroesofágico. Métodos: Se realizó un estudio observacional descriptivo en 37 pacientes con diagnóstico de enfermedad por reflujo gastroesofágico. Las variables analizadas fueron: edad, sexo, presencia de alteración, signos y síntomas, y localización. Se confeccionó base de datos con registros, se calcularon las frecuencias absolutas y porcentajes. Resultados: El 48,6 por ciento de los pacientes presentó alguna alteración bucal, como sensación de ardor o urente (40,5 por ciento) y eritema (35,1 por ciento). Entre las regiones afectadas se encontraron paladar blando/úvula (72,2 por ciento) y lengua (61,1 por ciento). Conclusiones: Casi la mitad de los pacientes afectados por reflujo gastroesofágico presentó alguna manifestación bucal. Las más frecuentemente encontradas fueron: la sensación de ardor o urente, eritema, sensación de boca seca y ulceraciones. Las localizaciones más frecuentes fueron paladar blando/úvula y lengua(AU)


ABSTRACT Introduction: Gastroesophageal reflux disease is a functional multifactorial disorder of the upper gastrointestinal tract. Oral alterations are considered to be extraesophageal manifestations of this disease. Objective: Determine the oral alterations found in patients with gastroesophageal reflux disease. Methods: An observational descriptive study was conducted of 37 patients diagnosed with gastroesophageal reflux disease. The variables analyzed were age, sex, presence of alteration, signs and symptoms, and location. A database was developed with the information recorded, and absolute frequencies and percentages were estimated. Results: Of the patients studied, 48.6 percent had some sort of oral alteration, such as a burning sensation (40.5 percent) and erythema (35.1 percent). The regions affected included the soft palate / uvula (72.2 percent) and the tongue (61.1 percent). Conclusions: Almost half of the patients affected by gastroesophageal reflux had some sort of oral manifestation, the most common of which were a burning sensation, erythema, a dry mouth sensation and ulcerations. The most common locations were the soft palate / uvula and the tongue(AU)


Assuntos
Humanos , Manifestações Bucais , Refluxo Gastroesofágico/diagnóstico , Epidemiologia Descritiva , Estudos Observacionais como Assunto
2.
Gastroenterol Hepatol ; 39(5): 311-7, 2016 May.
Artigo em Espanhol | MEDLINE | ID: mdl-26545949

RESUMO

INTRODUCTION: Barrett's oesophagus (BE) is an oesophageal injury caused by gastroesophageal acid reflux. One of the main aims of treatment in BE is to achieve adequate acid reflux control. OBJECTIVE: To assess acid reflux control in patients with BE based on the therapy employed: medical or surgical. METHODS: A retrospective study was performed in patients with an endoscopic and histological diagnosis of BE. Medical therapy with proton pump inhibitors (PPI) was compared with surgical treatment (Nissen fundoplication). Epidemiological data and the results of pH monitoring (pH time <4, prolonged reflux >5min, DeMeester score) were evaluated in each group. Treatment failure was defined as a pH lower than 4 for more than 5% of the recording time. RESULTS: A total of 128 patients with BE were included (75 PPI-treated and 53 surgically-treated patients). Patients included in the two comparison groups were homogeneous in terms of demographic characteristics. DeMeester scores, fraction of time pH<4 and the number of prolonged refluxes were significantly lower in patients with fundoplication versus those receiving PPIs (P<.001). Treatment failure occurred in 29% of patients and was significantly higher in those receiving medical therapy (40% vs 13%; P<.001). CONCLUSIONS: Treatment results were significantly worse with medical treatment than with anti-reflux surgery and should be optimized to improve acid reflux control in BE. Additional evidence is needed to fully elucidate the utility of PPI in this disease.


Assuntos
Esôfago de Barrett/tratamento farmacológico , Esôfago de Barrett/cirurgia , Fundoplicatura , Refluxo Gastroesofágico/tratamento farmacológico , Inibidores da Bomba de Prótons/uso terapêutico , Adulto , Esôfago/patologia , Esôfago/cirurgia , Feminino , Refluxo Gastroesofágico/complicações , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Retrospectivos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...